Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Two High Yield Pharmaceutical Stocks to Buy and Hold for the Next Decade
Seeking Alpha
Monday, July 4, 2011 - 9:24am
tags:
Abbott Laboratories, Novartis
Teva Markets its Generic Version of Lipitor in U.K., FT Reports
Bloomberg
Monday, July 4, 2011 - 9:23am
tags:
generics, UK, Lipitor, statins, Teva Pharmaceuticals, Pfizer
J&J-Bayer’s Xarelto Wins U.S. Approval for Hip Surgery Use
Bloomberg
Monday, July 4, 2011 - 9:21am
tags:
Bayer, JNJ, Xarelto
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Seeking Alpha
Monday, July 4, 2011 - 9:20am
tags:
Dendreon, prostate cancer, cancer immunotherapy, Cel-Sci, Cell Therapeutics, ImmunoCellular, Keryx, Teva Pharmaceuticals, Oncothyreon
Questcor hits 52-week high
Marketwatch
Monday, July 4, 2011 - 9:18am
tags:
Questcor Pharmaceuticals, MS, multiple sclerosis, Acthar
Jazz Drug Helps Keep Narcolepsy Sufferers Awake
Investors.com
Monday, July 4, 2011 - 9:15am
tags:
Jazz Pharmaceuticals, narcolepsy, Xyrem
Forest Seeks FDA Nod for COPD Drug
Yahoo/Zacks.com
Monday, July 4, 2011 - 9:14am
tags:
FDA, Forest Labs, COPD, Almirall, aclidinium bromide
Lannett Drops After FDA Approval With More Decisions Pending
Seeking Alpha
Monday, July 4, 2011 - 9:13am
tags:
FDA, Lannett, morphine sulfate
4-Star Stocks Poised to Pop: Merck
Motley Fool
Monday, July 4, 2011 - 9:12am
tags:
Merck
Dentsply Acquisition Delivers Smiles
Motley Fool
Monday, July 4, 2011 - 9:11am
tags:
M&A, Dentsply, AstraZeneca, dental, Astra Tech
Dendreon climbs 4% in premarket trading
Marketwatch
Friday, July 1, 2011 - 9:58am
tags:
Medicare, Dendreon, Provenge, prostate cancer
[video] The Next Big Thing In Biotech: Seattle Genetics
TheStreet.com
Friday, July 1, 2011 - 9:57am
tags:
Seattle Genetics
7 Rallying Biotech Stocks With Conservative Accounting Practices
Seeking Alpha
Friday, July 1, 2011 - 9:56am
tags:
Acorda Therapeutics, Incyte, Chelsea Therapeutics, Regeneron, Spectrum Pharmaceuticals, Jazz Pharmaceuticals, Neurocrine
Medicare Will Continue to Cover 2 Expensive Cancer Drugs
NY Times, NY
Friday, July 1, 2011 - 9:55am
tags:
Medicare, Provenge, prostate cancer, Dendreon, Roche, Avastin, breast cancer
Cramer Interviews Celgene CEO Hugin
CNBC
Friday, July 1, 2011 - 9:53am
tags:
Celgene, Pharma CEOs, Bob Hugin
Merck says Gardasil, Cubicin approved in Japan
Yahoo/AP
Friday, July 1, 2011 - 9:47am
tags:
Gardasil, Japan, Merck, Cubicin, Cubist Pharmaceuticals
3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review
Motley Fool
Friday, July 1, 2011 - 9:44am
tags:
FDA, Bristol-Myers Squibb, AstraZeneca, Pfizer, Incyte, Novartis, ruxolitinib, Apixaban, Dapagliflozin
Dendreon Wins Final Medicare Coverage Decision on Prostate Cancer Drug
Bloomberg
Thursday, June 30, 2011 - 7:34pm
tags:
prostate cancer, Dendreon, Provenge, Medicare
Change in Warner Chilcott's R&D
Yahoo/Zacks.com
Thursday, June 30, 2011 - 7:32pm
tags:
R&D, Warner Chilcott, P&G
6 Healthcare Companies With July Catalysts
Seeking Alpha
Thursday, June 30, 2011 - 7:26pm
tags:
Alexa, AstraZeneca, Bristol-Myers Squibb, JNJ, Seattle Genetics, Transcept

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.